What challenges remain in chronic myeloid leukemia research?

Haematologica. 2013 Aug;98(8):1168-72. doi: 10.3324/haematol.2013.090381.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Benzamides / pharmacology
  • Benzamides / therapeutic use
  • Fusion Proteins, bcr-abl / immunology
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Piperazines / pharmacology
  • Piperazines / therapeutic use
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use
  • Randomized Controlled Trials as Topic / methods
  • Translational Research, Biomedical / trends

Substances

  • BCR-ABL1 fusion protein, human
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Fusion Proteins, bcr-abl
  • nilotinib